Impact of introduction of sildenafil on other treatment modalities for erectile dysfunction: A study of nationwide and local hospital sales

International Journal of Impotence Research

Volumn 16, Issue 6, 2004, Pages 527-530

  Jiann, B P ^a   Yu, C C ^a   Su, C C ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b YUAN'S GENERAL HOSPITAL   (Taiwan)

Author keywords

Alprostadil; Erectile dysfunction; Penile implant; Sildenafil; Trend

Indexed keywords

PROSTAGLANDIN E1; SILDENAFIL;

ADULT; AGED; ARTICLE; DRUG MARKETING; ERECTILE DYSFUNCTION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS PROSTHESIS; PRIORITY JOURNAL; TAIWAN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALPROSTADIL; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE PROSTHESIS; PIPERAZINES;

EID: 10844288797     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901259     Document Type: Article

References (10)

1. Krane RJ. Changes in ED therapy in the Viagra era. World J Urol 2001; 19: 23-24.
2. Carson CC et al. The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update. Urology 2002; 60(Suppl 2): 12-27.
3. Padma-Nathan H et al. A 4-year update on the safety of sildenafil citrate (Viagra®). Urology 2002; 60(Suppl 2): 67-90.
4. Wysowski DK, Swann J. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003; 169: 1040-1042.
5. Wilson EC et al. The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions. Pharmacoeconomics 2002; 20: 879-889.
6. Montorsi F et al. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate. Int J Impot Res 2003; 15: 444-449.
7. Jarow JP, Burnett AL, Geringer AM. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162: 722-725.
8. Jiann BP et al. What we learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical practice. Int J Impot Res 2003; 15: 412-417.
9. Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment. J Urol 2003; 169: 1999-2007.
10. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151: 54-61.